T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$1.96B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.57B |
| 4 |
GE Aerospace
GE
|
+$1.55B |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$1.43B |
Top Sells
| 1 |
Tesla
TSLA
|
+$2.81B |
| 2 |
Booking.com
BKNG
|
+$2.45B |
| 3 |
RHT
Red Hat Inc
RHT
|
+$1.8B |
| 4 |
JPMorgan Chase
JPM
|
+$1.31B |
| 5 |
State Street
STT
|
+$1.14B |
Sector Composition
| 1 | Healthcare | 18.46% |
| 2 | Technology | 17.53% |
| 3 | Financials | 14.18% |
| 4 | Consumer Discretionary | 14.02% |
| 5 | Communication Services | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Quanta Services
PWR
$57B
| $8.51M | ﹤0.01% |
282,780
| – | – |
|
|
DESP
1327
DELISTED
Despegar.com
DESP
| $8.44M | ﹤0.01% |
679,909
-208,460
| -23% | -$2.59M |
|
1328
Goodyear
GT
$2.43B
| $8.42M | ﹤0.01% |
412,394
+4,300
| +1% | +$87.8K |
|
1329
Qiagen
QGEN
$9.82B
| $8.34M | ﹤0.01% |
228,384
+106,709
| +88% | +$3.9M |
|
1330
Amicus Therapeutics
FOLD
$2.46B
| $8.29M | ﹤0.01% |
865,277
-1,623,357
| -65% | -$15.6M |
|
1331
OGE Energy
OGE
$8.96B
| $8.27M | ﹤0.01% |
210,926
+5,909
| +3% | +$232K |
|
|
ACIA
1332
DELISTED
Acacia Communications, Inc. Common Stock
ACIA
| $8.26M | ﹤0.01% |
+217,370
| New | +$8.26M |
|
1333
Viavi Solutions
VIAV
$2.69B
| $8.24M | ﹤0.01% |
820,331
-469,576
| -36% | -$4.72M |
|
|
USX
1334
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $8.09M | ﹤0.01% |
1,441,423
+639,551
| +80% | +$3.59M |
|
1335
CareDx
CDNA
$720M
| $8.06M | ﹤0.01% |
+320,688
| New | +$8.06M |
|
1336
Helmerich & Payne
HP
$2.1B
| $8.01M | ﹤0.01% |
167,004
-19,800
| -11% | -$949K |
|
1337
Synaptics
SYNA
$2.72B
| $7.98M | ﹤0.01% |
214,553
+4,228
| +2% | +$157K |
|
1338
Leggett & Platt
LEG
$1.3B
| $7.98M | ﹤0.01% |
222,666
| – | – |
|
1339
Y-mAbs Therapeutics
YMAB
$390M
| $7.92M | ﹤0.01% |
389,497
+97
| +0% | +$1.97K |
|
1340
Standex International
SXI
$2.47B
| $7.69M | ﹤0.01% |
114,510
-999
| -0.9% | -$67.1K |
|
|
ZAYO
1341
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $7.63M | ﹤0.01% |
334,168
+21,816
| +7% | +$498K |
|
1342
Xerox
XRX
$463M
| $7.62M | ﹤0.01% |
385,740
| – | – |
|
1343
Helix Energy Solutions
HLX
$914M
| $7.58M | ﹤0.01% |
+1,401,901
| New | +$7.58M |
|
1344
ProQR Therapeutics
PRQR
$231M
| $7.58M | ﹤0.01% |
+480,425
| New | +$7.58M |
|
1345
Williams-Sonoma
WSM
$24B
| $7.5M | ﹤0.01% |
297,210
+2,786
| +0.9% | +$70.3K |
|
1346
Fluor
FLR
$6.63B
| $7.48M | ﹤0.01% |
232,424
-100
| -0% | -$3.22K |
|
1347
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $7.45M | ﹤0.01% |
823,661
-449,658
| -35% | -$4.07M |
|
|
VRAY
1348
DELISTED
ViewRay, Inc.
VRAY
| $7.42M | ﹤0.01% |
1,222,984
+623
| +0.1% | +$3.78K |
|
|
TPIC
1349
DELISTED
TPI Composites
TPIC
| $7.42M | ﹤0.01% |
301,682
+158,274
| +110% | +$3.89M |
|
1350
Corvus Pharmaceuticals
CRVS
$434M
| $7.29M | ﹤0.01% |
1,986,163
-2,010
| -0.1% | -$7.38K |
|